Screener
Arcus Biosciences RCUS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 18 | 15 |
| Total current assets | 756 | 1,007 |
| Long-term marketable securities | 73 | 29 |
| Property and equipment, net | 36 | 40 |
| Other noncurrent assets | 59 | 63 |
| Total assets | $924 | $1,139 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's PP&E (net)?
- Arcus Biosciences (RCUS) reported PP&E (net) of $36M in Q2 2026.
- How has Arcus Biosciences's PP&E (net) changed year-over-year?
- Arcus Biosciences's PP&E (net) decreased by 18.2% year-over-year, from $44M to $36M.
- What is the long-term trend for Arcus Biosciences's PP&E (net)?
- Over 5 years (2020 to 2025), Arcus Biosciences's PP&E (net) has grown at a 29.9% compound annual growth rate (CAGR), from $10.81M to $40M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Arcus Biosciences's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude